
    
      As a traditional chinese medicine, the Injection of DanShenDuoFenSuanYan (the Injection of
      Depsides Salts From Salvia Miltiorrhiza) was approved by State Food and Drug Administration
      of China in May,2005. This cardiovascular drug is one of the few Traditional Chinese Medicine
      pharmaceuticals where the active ingredients have been identified in the molecular levels. In
      its 8 years marketing in China, there is no serious adverse drug reactions.

      In this study, clinical pharmacists in selected hospitals will record the clinical use and
      the adverse drug reactions/ adverse drug events of this injection.

      This real world study for the Injection of DanShenDuoFenSuanYan with 30400 patients will be
      conducted from June.2012 to May.2014.
    
  